Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $14,096.65 mil
Piotroski score: 3
Financial data not available
Latest News
-
BridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call Transcript
Fri, May 8, 2026 11:31 AM
-
BridgeBio Pharma Inc files for mixed shelf size not disclosed - SEC filing
Fri, May 8, 2026 6:17 AM
-
BridgeBio Pharma (NASDAQ:BBIO) Q1 2026 Revenue Beat Driven by Attruby Sales Surge, Shares Jump
Thu, May 7, 2026 8:43 PM
-
Transcript : BridgeBio Pharma, Inc., Q1 2026 Earnings Call, May 07, 2026
Thu, May 7, 2026 8:20 PM
-
BridgeBio Pharma: Q1 Earnings Snapshot
Thu, May 7, 2026 4:23 PM
-
BridgeBio Board of Directors Authorized $500M Stock Buyback
Thu, May 7, 2026 4:12 PM
-
BridgeBio Pharma Q1 EPS $(0.84) Misses $(0.67) Estimate, Sales $194.515M Beat $177.937M Estimate
Thu, May 7, 2026 4:10 PM
-
BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
Thu, May 7, 2026 4:01 PM
-
BridgeBio to Participate in May and June Investor Conferences
Wed, May 6, 2026 4:01 PM
-
BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition
Wed, May 6, 2026 3:48 PM
Key Financials
Financial data not available